Functional genomics: From genes to new therapies

Drug Discovery Today

Volumn 4, Issue 3, 1999, Pages 109-114

  Dyer, Mark R ^a   Cohen, Dalia ^a   Herrling, Paul L ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; GENETIC ANALYSIS; HUMAN; MEDICAL GENETICS; PROTEIN EXPRESSION; REVIEW;

EID: 0033102657     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01310-0     Document Type: Review

References (19)

1. Cohen, D., Chumakov, I. and Weissenbach, J. (1993) Nature 366, 698-701
2. Watson, J.D. (1990) Science 248, 44-49
3. Fields, C. et al. (1994) Nat. Genet. 7, 345-346
4. Selkoe, D.J. (1997) Science 275, 630-631
5. Yankner, B.A. (1996) Neuron 16, 921-932
6. Goedert, M. (1997) Nature 388, 232-233
7. Polymeropoulos, M.H. et al. (1997) Science 276, 2045-2047
8. Kahn, C.R. et al. (1996) Annu. Rev. Med. 47, 509-531
9. Postma, D.S. et al. (1995) New Engl. J. Med. 333, 894-900
10. Maddison, P.J. et al., eds (1993) Oxford Textbook of Rheumatology (Vol. 2), Oxford Medical Publications
11. Herrling, P.L. (1998) Nature 392 (Suppl.), 32-35
12. Liang, P. and Pardee, A.B. (1992) Science 257, 967-971
13. Shiue, L. (1997) Drug Dev. Res. 41, 142-159
14. Lillie, J. (1997) Drug Dev. Res. 41, 160-172
15. Wilkins, M.R. et al., eds (1997) Proteome Research: New Frontiers in Functional Genomics, Springer-Verlag
16. Mushegian, A.R. et al. (1998) Genome Res. 8, 590-598
17. Kingsbury, D.T. (1997) Drug Dev. Res. 41, 120-128
18. Patterson, M. and Handel, M., Eds (1998) Trends Guide to Bioinformatics, Elsevier Science
19. Venter, J.C. et al. (1998) Science 280, 1540-1542